Home
Resources
Publications
Plasminogen Activator inhibitor-1 Protects Endothelial Cells From FasL-mediated Apoptosis

Plasminogen Activator inhibitor-1 Protects Endothelial Cells From FasL-mediated Apoptosis

Khalid Bajou, Hongjun Peng, Walter E Laug, Catherine Maillard, Agnes Noel, Jean M Foidart, Joseph A Martial, Yves A DeClerck

Cancer Cell. 2008 Oct 7;14(4):324-34.

PMID: 18835034

Abstract:

Plasminogen activator inhibitor-1 (PAI-1) paradoxically enhances tumor progression and angiogenesis; however, the mechanism supporting this role is not known. Here we provide evidence that PAI-1 is essential to protect endothelial cells (ECs) from FasL-mediated apoptosis. In the absence of host-derived PAI-1, human neuroblastoma cells implanted in PAI-1-deficient mice form smaller and poorly vascularized tumors containing an increased number of apoptotic ECs. We observed that knockdown of PAI-1 in ECs enhances cell-associated plasmin activity and increases spontaneous apoptosis in vitro. We further demonstrate that plasmin cleaves FasL at Arg144-Lys145, releasing a soluble proapoptotic FasL fragment from the surface of ECs. The data provide a mechanism explaining the proangiogenic activity of PAI-1.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP140208237	Plasminogen activator inhibitor 1 (PAI-1) human		140208-23-7	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: